Temporary measures in relation to value added tax for COVID-19 vaccines and in vitro diagnostic medical devicesNov 26, 2020for
Towards a more sustainable single market for business and consumersConsumer protectionNov 25, 2020abstention
Strengthening Media Freedom: the Protection of Journalists in Europe, Hate Speech, Disinformation and the Role of PlatformsDigitalNov 25, 2020for
Application of Union tariff rate quotas and other import quotasInternational tradeUnited KingdomNov 25, 2020for
Commission Implementing Regulation (EU) 2020/1511 of 16 October 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, picloram, prosulfocarb, sulphur, triflusulfuron and tritosulfuronFood and agricultureNov 25, 2020against
The draft Commission implementing regulation approving carbendazim as an existing active substance for use in biocidal products of product-types 7 and 10Consumer protectionClimate and environmentEconomy and budgetNov 25, 2020against
Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”)Worker’s rightsHealthNov 13, 2020for
Sustainable Europe Investment Plan - How to finance the Green DealClimate changeClimate and environmentEnergyNov 13, 2020for
